A Q&A with Executive Editor Mark A. Newman about the exciting next step for the Endocrine Society’s flagship member magazine, Endocrine News. June will mark a historical milestone for Endocrine News magazine as it fully transitions to an online-only publication. The magazine’s Executive Editor, Mark A. Newman, has been leading the publication since 2013 and...
Medical researchers have identified a dangerous and deceptive trend in the illicit drug market after two nondiabetic patients were admitted to intensive care with life-threatening hypoglycemia following heroin use. The cases, occurring years apart but linked by the same rare clinical presentation, reveal that heroin supplies are being contaminated with glipizide, a potent prescription medication...
Patients with classic adrenal hyperplasia (CAH) may be able to reduce their glucocorticoid (GC) doses with crinecerfont, a first-in-class corticotropin-releasing factor type 1 receptor antagonist, according to two studies recently published in The Journal of Clinical Endocrinology & Metabolism. Neurocrine Biosciences, Inc. funded the studies, and the company is marketing crinecerfont as CRENESSITY®. The two papers...
Endocrine Society Advocacy Victories – Join Endocrine Society Advocacy Campaigns The Endocrine Society is an advocacy leader representing the interests of members to policymakers. During the past year we have had many advocacy victories including: We also have several ways for you to join us in advocacy: Endocrine Society Advocates for Access to Affordable Anti-Obesity...
Each May in the U.S. is National Osteoporosis Awareness and Prevention Month which is observed to raise awareness about osteoporosis as well as promote prevention and early detection. Bone health is one of the cornerstones of endocrine science and practice, so we felt that this was the perfect issue to highlight some of the recent...
ENDO 2026 in Chicago will include a session titled “Year in Bone” featuring two leading experts in bone research who will review and discuss the most influential and cutting‑edge publications from the past year. Endocrine News provides a sneak peek of the talks on this “mysterious and dynamic tissue.” Last February, a paper appeared in...
Endocrine Society member Matthias Tschöp, MD, has been awarded the 2026 Rolf Luft Award for outstanding groundbreaking scientific contributions to fields of diabetes and obesity basic research leading to important clinical implications. He shares the award with Richard Dennis DiMarchi from Indiana University in Bloomington. Tschöp, president of Ludwig-Maximilians-Universität München (LMU), is an internationally renowned...
Women’s bone health takes center stage in Chicago during the symposium “Hot and Flashy: Topics in Menopause,” on Saturday June 13. From catching endocrinologists up regarding menopause care and past regulatory missteps to estrogen’s impact on bone health and the myriad non-hormonal options, this ENDO 2026 symposium will definitely give attendees something to talk about!...
ENDO 2026 in Chicago will include a session titled “Year in Bone” featuring two leading experts in bone research who will review and discuss the most influential and cutting‑edge publications from the past year. Endocrine News provides a sneak peek of the talks on this “mysterious and dynamic tissue.” Last February, a paper appeared in...
